254 filings
Page 2 of 13
DEFA14A
ajozgkxqxo4nqrf
3 Nov 23
Additional proxy soliciting materials
4:19pm
8-K
il1ze2qc8
23 Oct 23
Amendments to Articles of Incorporation or Bylaws
4:44pm
8-K
n9g2gvn y3zdpvs
25 Sep 23
Changes in Registrant's Certifying Accountant
4:20pm
8-K
3dt0jtzggtcb91p
8 Sep 23
Regulation FD Disclosure
4:20pm
8-K
qzxttf
1 Sep 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:17pm
8-K/A
gdrgkpb3d5mi76bo93
21 Aug 23
Changes in Registrant's Certifying Accountant
5:13pm
NT 10-Q
wam 88vgt20fx76b
15 Aug 23
Notice of late quarterly filing
8:30am
424B5
f0peqztzj yocj
20 Jul 23
Prospectus supplement for primary offering
4:07pm
8-K
ndu0sy cs4muuic5f
19 Jul 23
Genprex Announces $7.5 Million Registered Direct Offering PricedĀ At-the-MarketĀ Under Nasdaq Rules
4:06pm
8-K
11brh1j5 7ltxtx5
18 Jul 23
Genprex Signs Exclusive License to Additional Diabetes Technology with the University of Pittsburgh
9:06am
8-K
8gn95h1q82gg2n3u3q
14 Jul 23
Changes in Registrant's Certifying Accountant
4:32pm
8-K
ci6hf0eyq0uum9sgblgh
27 Jun 23
Submission of Matters to a Vote of Security Holders
4:28pm
EFFECT
5a95 7a72fhs7kfmch
12 Jun 23
Notice of effectiveness
12:15am
CORRESP
eawqt2v fr93q
7 Jun 23
Correspondence with SEC
12:00am
8-K
upngrigwh4vf
26 May 23
Other Events
4:42pm
NT 10-Q
pa29yx83gm
16 May 23
Notice of late quarterly filing
8:35am